Melanotan I was subsequently sold and further developed by a pharmaceutical company into a drug called afamelanotide, whilst melanotan II was developed by a separate company into a drug called bremelanotide
Teredesai A., Wohrmann T., Schlage W
But they can also bring extra hurdles, such as self-injection, training, storage needs and device handling
Less common but important reactions Beyond the common injection site reactions, there are some less frequent but more significant side effects that you should be aware of
Neurotox Res 37(3):491507 Rai SN et al (2021) The role of vitamins in neurodegenerative disease: an update
Some may notice changes in just a few months, while others might take more time